Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

Show other versions (1)

We have analysed data on exacerbation rates, Expanded Disability Status Scale (EDSS) scores, and lesion burdens using the results of two neutralizing antibody (NAB) assays (CPE and MxA) from the pivotal relapsing-remitting multiple sclerosis (MS) trial of interferon beta-1b (IFNB) with a longitudina...

Full description

Bibliographic Details
Main Authors: Petkau, A, White, R, Ebers, G, Reder, A, Sibley, W, Lublin, F, Paty, D, Duquette, P, Girard, M, Despault, L, DuBois, R, Knobler, R, Kelley, L, Francis, G, Lapierre, Y, Antel, J, Freedman, M, Hum, S, Greenstein, J, Mishra, B, Muldoon, J, Whitaker, J, Evans, B, Layton, B, Laguna, J
Format: Journal article
Language:English
Published: 2004

Similar Items